P-TEFb, a Cyclin-dependent Kinase Controlling Elongation by RNA Polymerase II

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2000 Mar 25

PMID 10733565

Citations 298

Authors

D H Price

Affiliations

Soon will be listed here.

Citing Articles

Promoter-proximal RNA polymerase II termination regulates transcription during human cell type transition.

Lysakovskaia K, Devadas A, Schwalb B, Lidschreiber M, Cramer P Nat Struct Mol Biol. 2025; .

PMID: 39934431 DOI: 10.1038/s41594-025-01486-9.

Monocytes across life span in HIV infection: lights and shadows.

Neri A, Olivieri G, Pighi C, Amodio D, Cotugno N, Palma P Curr Opin HIV AIDS. 2025; 20(2):133-144.

PMID: 39774439 PMC: 11809736. DOI: 10.1097/COH.0000000000000910.

Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal.

Cisneros W, Soliman S, Walter M, Simons L, Cornish D, De Fabritiis S PLoS Pathog. 2024; 20(9):e1012083.

PMID: 39259751 PMC: 11419360. DOI: 10.1371/journal.ppat.1012083.

A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells.

Alberio T, Shallak M, Shaik A, Accolla R, Forlani G Viruses. 2024; 16(8).

PMID: 39205150 PMC: 11359826. DOI: 10.3390/v16081176.

Keep calm and reboot - how cells restart transcription after DNA damage and DNA repair.

Donnio L, Giglia-Mari G FEBS Lett. 2024; 599(2):275-294.

PMID: 38991979 PMC: 11771587. DOI: 10.1002/1873-3468.14964.

References

Bieniasz P, Grdina T, Bogerd H, Cullen B . Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism. Mol Cell Biol. 1999; 19(7):4592-9. PMC: 84257. DOI: 10.1128/MCB.19.7.4592. View

Isel C, Karn J . Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. J Mol Biol. 1999; 290(5):929-41. DOI: 10.1006/jmbi.1999.2933. View

Garber M, Jones K . HIV-1 Tat: coping with negative elongation factors. Curr Opin Immunol. 1999; 11(4):460-5. DOI: 10.1016/S0952-7915(99)80077-6. View

Napolitano G, Licciardo P, Gallo P, Majello B, Giordano A, Lania L . The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity. AIDS. 1999; 13(12):1453-9. DOI: 10.1097/00002030-199908200-00003. View

Majello B, Napolitano G, Giordano A, Lania L . Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo. Oncogene. 1999; 18(32):4598-605. DOI: 10.1038/sj.onc.1202822. View

Marshall N, Dahmus G, Dahmus M . Regulation of carboxyl-terminal domain phosphatase by HIV-1 tat protein. J Biol Chem. 1998; 273(48):31726-30. DOI: 10.1074/jbc.273.48.31726. View

Garber M, Wei P, Kewalramani V, Mayall T, Herrmann C, Rice A . The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 1998; 12(22):3512-27. PMC: 317238. DOI: 10.1101/gad.12.22.3512. View

Karn J . Tackling Tat. J Mol Biol. 1999; 293(2):235-54. DOI: 10.1006/jmbi.1999.3060. View

Taube R, Fujinaga K, Wimmer J, Barboric M, Peterlin B . Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology. 1999; 264(2):245-53. DOI: 10.1006/viro.1999.9944. View

10.

Fu T, Peng J, Lee G, Price D, Flores O . Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription. J Biol Chem. 1999; 274(49):34527-30. DOI: 10.1074/jbc.274.49.34527. View

11.

Taube R, Fujinaga K, Irwin D, Wimmer J, Geyer M, Peterlin B . Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1. J Virol. 2000; 74(2):892-8. PMC: 111610. DOI: 10.1128/jvi.74.2.892-898.2000. View

12.

Kanazawa S, Okamoto T, Peterlin B . Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity. 2000; 12(1):61-70. DOI: 10.1016/s1074-7613(00)80159-4. View

13.

Lis J, Mason P, Peng J, Price D, Werner J . P-TEFb kinase recruitment and function at heat shock loci. Genes Dev. 2000; 14(7):792-803. PMC: 316500. View

14.

Sehgal P, Darnell Jr J, Tamm I . The inhibition by DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole) of hnRNA and mRNA production in HeLa cells. Cell. 1976; 9(3):473-80. DOI: 10.1016/0092-8674(76)90092-1. View

15.

Tamm I, Kikuchi T, Darnell Jr J, Salditt-Georgieff M . Short capped hnRNA precursor chains in HeLa cells: continued synthesis in the presence of 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Biochemistry. 1980; 19(12):2743-8. DOI: 10.1021/bi00553a032. View

16.

Zandomeni R, Mittleman B, Bunick D, Ackerman S, Weinmann R . Mechanism of action of dichloro-beta-D-ribofuranosylbenzimidazole: effect on in vitro transcription. Proc Natl Acad Sci U S A. 1982; 79(10):3167-70. PMC: 346375. DOI: 10.1073/pnas.79.10.3167. View

17.

Kao S, Calman A, Luciw P, Peterlin B . Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature. 1987; 330(6147):489-93. DOI: 10.1038/330489a0. View

18.

Chodosh L, Fire A, Samuels M, Sharp P . 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J Biol Chem. 1989; 264(4):2250-7. View

19.

Majello B, Napolitano G, Lania L . Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation. AIDS. 1998; 12(15):1957-64. DOI: 10.1097/00002030-199815000-00006. View

20.

Herrmann C, Carroll R, Wei P, Jones K, Rice A . Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J Virol. 1998; 72(12):9881-8. PMC: 110500. DOI: 10.1128/JVI.72.12.9881-9888.1998. View